UPC Analytics
ENDE
Analytics28Cases23Decisions20Judges63Parties6Firms

Parties

Filing frequency, side mix, win records, firms typically retained — by corporate group or standalone party.

Substantive (main) cases onlyfalseClear all

Samsung Bioepis NL B.V.

Operating company
Clear and return to cohort view
Total cases
10
Claimant-side
5
Respondent-side
5
Win rate
0%
Top opponents
  • Alexion Pharmaceuticals, Inc.5
Top firms
  • Simmons & Simmons LLP3
  • Freshfields PartG mbB2
  • Freshfields Bruckhaus Deringer1
Recent cases
  • 2025-08-13UPC_CoA_744/2025WithdrawnSamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-07-22UPC_CFI_674/2025—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-01-23UPC_CFI_51/2025—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-01-22UPC_CFI_40/2025Costs onlySamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2024-11-08UPC_APP_60271/2024—Name not displayed for GDPR reasons. Represented by Jochen HÖHFELD v Alexion Pharmaceuticals, Inc.
  • 2024-07-26UPC_APP_43786/2024Costs onlySamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2024-07-11UPC_CoA_402/2024Procedural onlyAlexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V.
  • 2024-03-19UPC_CFI_123/2024PI deniedAlexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V.
  • —APL_40470/2024PI deniedAlexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V.
  • —UPC_APP_8340/2025DismissedAlexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V.